4.3 Article

Targeted inhibition of VEGF receptor 2: an update on ramucirumab

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs

Eva-Maria Eleonora Hedlund et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies

Justin N. Bottsford-Miller et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Review Oncology

Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy

Weijing Sun

JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)

Review Biochemistry & Molecular Biology

Basic and Therapeutic Aspects of Angiogenesis

Michael Potente et al.

Review Biochemistry & Molecular Biology

Tumor angiogenesis: molecular pathways and therapeutic targets

Sara M. Weis et al.

NATURE MEDICINE (2011)

Article Multidisciplinary Sciences

Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy

Jenny Yao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies

Matthew C. Franklin et al.

STRUCTURE (2011)

Article Biochemistry & Molecular Biology

PlGF Blockade Does Not Inhibit Angiogenesis during Primary Tumor Growth

Carlos Bais et al.

Review Oncology

An overview of small-molecule inhibitors of VEGFR signaling

S. Percy Ivy et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Article Oncology

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

Takuya Osada et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Article Medicine, General & Internal

Sorafenib in advanced hepatocellular carcinoma

Josep M. Llovet et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Medicine, General & Internal

Molecular origins of cancer: Tumor angiogenesis

Robert S. Kerbel

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Oncology

Modes of resistance to anti-angiogenic therapy

Gabriele Bergers et al.

NATURE REVIEWS CANCER (2008)

Article Medicine, General & Internal

Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer

A. Giatromanolaki et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Medicine, General & Internal

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Robert J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Alan Sandler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Oncology

Vascular endothelial growth factor signaling pathways: Therapeutic perspective

Marcin Kowanetz et al.

CLINICAL CANCER RESEARCH (2006)

Article Biochemistry & Molecular Biology

Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2

Hua-Quan Miao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Review Cell Biology

VEGF receptor signalling - in control of vascular function

AK Olsson et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Article Medicine, General & Internal

Circulating angiogenic factors and the risk of preeclampsia

RJ Levine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Endocrinology & Metabolism

Vascular endothelial growth factor: Basic science and clinical progress

N Ferrara

ENDOCRINE REVIEWS (2004)

Article Medicine, General & Internal

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

H Hurwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Biochemistry & Molecular Biology

The biology of VEGF and its receptors

N Ferrara et al.

NATURE MEDICINE (2003)

Article Oncology

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

L Ryden et al.

BREAST CANCER RESEARCH AND TREATMENT (2003)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.